Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50 (0.38%) Natco Pharma informs about Press Release
Date: 19-06-2015Natco Pharma has informed about a Press Release dated June 19, 2015 titled ‘US Court of Appeals for the Federal Circuit Finds TevaS 808 COPAXONE Patent Invalid’.
The above information is a part of company’s filings submitted to BSE.